Hearing Loss May Affect Neurocognitive Abilities of Childhood Cancer Survivors
Findings show that survivors with severe hearing loss are at a significantly increased risk for neurocognitive deficits, independent of what type of therapy they receive.
Findings show that survivors with severe hearing loss are at a significantly increased risk for neurocognitive deficits, independent of what type of therapy they receive.
St. Jude Children’s Research Hospital scientists have found that variations of inherited genes are associated with hearing loss in young cancer patients treated with cisplatin, a drug widely used to treat brain tumors and other types of cancer.